Press release
At a CAGR of 9.4%, Meningococcal Vaccines Market: Rising Demand and Growth Trends Toward US$ 9.2 Bn by 2031- TMR Report
Meningococcal Vaccines
The global meningococcal vaccines market was valued at US$ 4.2 billion in 2021 and is projected to expand at a CAGR of 9.4% from 2022 to 2031. By the end of 2031, the industry is expected to reach US$ 9.2 billion. Key factors propelling this growth include expanding vaccination coverage, increasing outbreaks of meningococcal infections, and the development of novel vaccine formulations.
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1666
Analyst Viewpoint
Industry analysts anticipate continued market expansion driven by global immunization efforts, the introduction of combination vaccines, and increasing investments in R&D. Emerging economies are expected to contribute significantly to growth as governments focus on improving healthcare infrastructure and disease prevention strategies. However, high vaccine costs and supply chain challenges may pose barriers to widespread adoption.
Key Market Drivers
Rising Incidence of Meningococcal Disease - Increasing cases of meningitis outbreaks globally are fueling vaccine demand.
Government Immunization Programs - National vaccination programs and public health initiatives are driving market expansion.
Advancements in Vaccine Technology - Development of conjugate and recombinant vaccines enhances vaccine efficacy and market penetration.
Increasing Awareness and Preventive Healthcare Initiatives - Growing emphasis on early vaccination to reduce disease burden.
Expanding Healthcare Infrastructure in Emerging Markets - Greater access to vaccines due to improved healthcare facilities and distribution networks.
Recent Developments
2023: Pfizer announced the launch of a next-generation meningococcal conjugate vaccine with broad serogroup coverage.
2022: GlaxoSmithKline (GSK) received regulatory approval for a novel pentavalent meningococcal vaccine.
2021: Sanofi Pasteur expanded its global vaccine production capacity to meet rising demand.
2020: The World Health Organization (WHO) introduced new meningococcal vaccination guidelines to enhance global immunization coverage.
2019: Serum Institute of India launched an affordable meningococcal vaccine for low-income countries.
Key Players
Sanofi SA
Novartis International
GlaxoSmithKline plc
Pfizer Inc.
Nuron Biotech
JN-International Medical Corporation
Serum Institute of India Ltd
Baxter International
Biomed Pvt. Ltd
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1666
Market Trends and Opportunities
Development of Multivalent Vaccines - Growing demand for vaccines covering multiple meningococcal serogroups.
Increase in Public-Private Partnerships - Collaborations between governments and pharmaceutical companies to boost vaccine production and accessibility.
Advancements in mRNA Vaccine Technology - Research into mRNA-based meningococcal vaccines as a next-generation immunization strategy.
Rising Focus on Pediatric Immunization - Increasing efforts to include meningococcal vaccines in routine childhood vaccination schedules.
Expansion of Travel Vaccination Programs - Growth in vaccine demand due to rising global travel and tourism-related health precautions.
Market Segmentation
By Vaccine Type
Conjugate Vaccines
Polysaccharide Vaccines
Combination Vaccines
Recombinant Vaccines
By Age Group
Infants & Young Children
Adolescents & Adults
Elderly Population
By Distribution Channel
Hospitals & Clinics
Retail Pharmacies
Government & Non-Governmental Organizations (NGOs)
Future Outlook
The global meningococcal vaccines market is expected to experience sustained growth, with rising investments in vaccine R&D and expansion in immunization programs. Companies focusing on the development of cost-effective and broad-spectrum vaccines will gain a competitive advantage. Additionally, increased global health initiatives to eliminate meningococcal disease will support market expansion.
Regional Analysis
North America - Leads the market due to strong immunization policies and high healthcare expenditure.
Europe - Growth driven by government-funded vaccination programs and increasing awareness.
Asia-Pacific - Emerging economies like China and India exhibit strong growth potential due to expanding healthcare infrastructure.
Latin America & Middle East & Africa - Increasing immunization coverage and public health initiatives fuel market growth.
Explore Latest Research Reports by Transparency Market Research:
Healthcare Biometrics Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-biometrics-market-to-surpass-us-7408-billion-by-2035-driven-by-advancements-in-security-digital-health-solutions-tmr-insights
Healthcare Contract Research Outsourcing Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-contract-research-outsourcing-market-to-surpass-us-6309-billion-by-2035-driven-by-increasing-demand-for-cost-effective-drug-development
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release At a CAGR of 9.4%, Meningococcal Vaccines Market: Rising Demand and Growth Trends Toward US$ 9.2 Bn by 2031- TMR Report here
News-ID: 3947380 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
